Close

Wall St. falls as healthcare, materials stumble

Go back to Wall St. falls as healthcare, materials stumble

FBR Capital Cuts Price Target on Express (EXPR) Following 2Q EPS Miss

August 25, 2016 7:00 AM EDT

FBR Capital reiterated a Market Perform rating on Express Inc. (NYSE: EXPR), and cut the price target to $13.00 (from $18.00), following the company's 2Q earnings report. EXPR reported an EPS miss of $0.13, versus the consensus of $0.17.

Analyst Susan Anderson commented, "EXPR reported a 2Q16 EPS... More

Stifel Cuts Price Target on Express (EXPR) to $15 Following 2Q EPS Miss

August 24, 2016 1:54 PM EDT

Stifel maintained a Buy rating on Express Inc. (NYSE: EXPR), and cut the price target to $15.00 (from $18.00), following the company's 2Q earnings report.

Analyst "Express reported 2Q EPS of $0.13, $0.04 below consensus and $0.02 below the low end of managements guidance. EPS decreased 48% vs.... More

Stifel Notes Rough Qtr. for Express (EXPR) Leading to Cut Outlook; Affirms at 'Buy'

August 24, 2016 8:00 AM EDT

Stifel affirms Express (NYSE: EXPR) at Buy with a price target of $18 following Q2 results and trimmed outlook issued earlier Wednesday.

Analyst Richard Jaffe commented today:

3Q Assortments Improve But is it Enough to Drive Traffic and Sales? Management believes that the fall assortment is more cohesive across... More